| Accession Number | 0000732717-26-000071 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 2, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sr. Exec. VP and Gen. Counsel | Common Stock | โ | Jan 29, 2026 | Grant/Award | 325,500 | โ | โ | 325,500 | Indirect | By Benefit Plan | View Details | |
Sr. Exec. VP and Gen. Counsel | Common Stock | โ | Jan 29, 2026 | Tax Withholding | 128,241 | $25.13 | $3,222,686.36 | 197,259 | Indirect | By Benefit Plan | View Details | |
Sr. Exec. VP and Gen. Counsel | Common Stock | โ | Jan 29, 2026 | Sale to Issuer | 130,191 | $25.13 | $3,271,709.80 | 67,068 | Indirect | By Benefit Plan | View Details | |
Sr. Exec. VP and Gen. Counsel | Common Stock | โ | Jan 29, 2026 | Sale to Issuer | 67,068 | โ | โ | 0 | Indirect | By Benefit Plan | View Details | |
Sr. Exec. VP and Gen. Counsel | Restricted Stock Units (2026) | Derivative | Jan 29, 2026 | Grant/Award | 74,612 | $0.00 | $0.00 | 74,612 | Direct | โ | View Details |